Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol versus dexmedetomidine as adjuvants to ondansetron for postoperative nausea and vomiting after laparoscopic cholecystectomy
PACTR202311673887516Phase 0Completed
- Sponsor
- Ain Shams University Faculty of Medicine
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of haloperidol, dexmedetomidine and ondansetron in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Ain Shams University Faculty of Medicine. Primary endpoint: Incidence of postoperative nausea and vomiting in the first 24 postoperative hours. Started May 2023; status: completed.
02
Drugs
haloperidoldexmedetomidineondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on PACTR202311673887516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202311673887516.